Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2h-transient focal ischemia

Neuroscience

Volumn 182, Issue , 2011, Pages 208-216

  Rojas, S ^a   Martin A ^b   Pareto, D ^a   Herance, J R ^a   Abad, S ^a   Ruiz A ^a   Flotats, N ^a   Gispert, J D ^a   Llop, J ^b   Gomez Vallejo V ^b   Planas, A M ^c  

^a Barcelona Biomedical Research Park   (Spain)

^b CIC BIOMAGUNE   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

11C flumazenil; Central benzodiazepine receptors; Infarction; Middle cerebral artery occlusion; PET; Stroke

Indexed keywords

FLUMAZENIL C 11; NEURON SPECIFIC NUCLEAR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; BRAIN INFARCTION; CONTROLLED STUDY; CORPUS STRIATUM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; REPERFUSION; SENSITIVITY ANALYSIS; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; ANIMALS; BINDING SITES; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FLUMAZENIL; MALE; NERVE DEGENERATION; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 79955464540     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.03.013     Document Type: Article

References (32)

1. Abe K., Kashiwagi Y., Tokumura M., Hosoi R., Hatazawa J., Inoue O. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats. Synapse 2004, 53:234-239.
2. Baird A.E., Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998, 18:583-609.
3. Barber P.A., Darby D.G., Desmond P.M., Yang Q., Gerraty R.P., Jolley D., Donnan G.A., Tress B.M., Davis S.M. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998, 51:418-426.
4. Canudas A.M., Friguls B., Planas A.M., Gabriel C., Escubedo E., Camarasa J., Camins A., Pallas M. MPP(+) injection into rat substantia nigra causes secondary glial activation but not cell death in the ipsilateral striatum. Neurobiol Dis 2000, 7:343-361.
5. Debruyne D., Abadie P., Barre L., Albessard F., Moulin M., Zarifian E., Baron J.C. Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies. Eur J Drug Metab Pharmacokinet 1991, 16:141-152.
6. Dohmen C., Bosche B., Graf R., Staub F., Kracht L., Sobesky J., Neveling M., Brinker G., Heiss W.D. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003, 34:2152-2158.
7. Fiehler J., Foth M., Kucinski T., Knab R., von Bezold M., Weiller C., Zeumer H., Rother J. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002, 33:79-86.
8. Frykholm P., Andersson J.L., Valtysson J., Silander H.C., Hillered L., Persson L., Olsson Y., Yu W.R., Westerberg G., Watanabe Y., Langstrom B., Enblad P. A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion-reperfusion primate model. Acta Neurol Scand 2000, 102:18-26.
9. Gerhard A., Neumaier B., Elitok E., Glatting G., Ries V., Tomczak R., Ludolph A.C., Reske S.N. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport 2000, 11(13):2957-2960.
10. Heiss W.D., Graf R., Fujita T., Ohta K., Bauer B., Lottgen J., Wienhard K. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 1997, 28:2045-2051. discussion 2051-2052.
11. Heiss W.D., Grond M., Thiel A., Ghaemi M., Sobesky J., Rudolf J., Bauer B., Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998, 29:454-461.
12. Heiss W.D., Kracht L., Grond M., Rudolf J., Bauer B., Wienhard K., Pawlik G. Early [(11)C]flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 2000, 31:366-369.
13. Henninger N., Fisher M. Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke 2007, 38:2779-2786.
14. Katchanov J., Waeber C., Gertz K., Gietz A., Winter B., Bruck W., Dirnagl U., Veh R.W., Endres M. Selective neuronal vulnerability following mild focal brain ischemia in the mouse. Brain Pathol 2003, 13:452-464.
15. Makino K., Kamiyama H., Takamura H., Gotoh S., Kobayashi N. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT. Ann Nucl Med 1999, 13(4):261-264.
16. Martín A., Boisgard R., Thézé B., Van Camp N., Kuhnast B., Damont A., Kassiou M., Dollé F., Tavitian B. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J Cereb Blood Flow Metab 2010, 30(1):230-241.
17. Martin A., Rojas S., Perez-Asensio F., Planas A.M. Transient benefits but lack of protection by sodium pyruvate after 2-hour middle cerebral artery occlusion in the rat. Brain Res 2009, 1272:45-51.
18. Matsuda H., Tsuji S., Kuji I., Shiba K., Hisada K., Mori H. Dual-tracer autoradiography using 125I-iomazenil and 99Tcm-HMPAO in experimental brain ischaemia. Nucl Med Commun 1995, 16:581-590.
19. Maziere M., Hantraye P., Prenant C., Sastre J., Comar D. Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4] benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot 1984, 35:973-976.
20. Minematsu K., Li L., Fisher M., Sotak C.H., Davis M.A., Fiandaca M.S. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 1992, 42:235-240.
21. Minematsu K., Li L., Sotak C.H., Davis M.A., Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992, 23:1304-1310. discussion 1310-1301.
22. Mishra N.K., Albers G.W., Davis S.M., Donnan G.A., Furlan A.J., Hacke W., Lees K.R. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010, 41:e25-e33.
23. Rojas S., Martin A., Justicia C., Falcon C., Bargallo N., Chamorro A., Planas A.M. Modest MRI signal intensity changes precede delayed cortical necrosis after transient focal ischemia in the rat. Stroke 2006, 37:1525-1532.
24. Rojas S., Martín A., Arranz M.J., Pareto D., Purroy J., Verdaguer E., Llop J., Gómez V., Gispert J.D., Millán O., Chamorro A., Planas A.M. Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab 2007, 27(12):1975-1986.
25. Sanabria-Bohorquez S.M., Labar D., Leveque P., Bol A., De Volder A.G., Michel C., Veraart C. [11C]flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification. Eur J Nucl Med 2000, 27:1674-1683.
26. Saur D., Buchert R., Knab R., Weiller C., Rother J. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke 2006, 37:2713-2719.
27. Savic I., Blomqvist G., Halldin C., Litton J.E., Gulyas B. Regional increases in [11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 1998, 97(5):279-286.
28. Savic I., Lindström P., Gulyás B., Halldin C., Andrée B., Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 62(8):1343-1351.
29. Sette G., Baron J.C., Young A.R., Miyazawa H., Tillet I., Barre L., Travere J.M., Derlon J.M., MacKenzie E.T. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 1993, 24:2046-2057. discussion 2057-2058.
30. Strbian D., Durukan A., Pitkonen M., Marinkovic I., Tatlisumak E., Pedrono E., Abo-Ramadan U., Tatlisumak T. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 2008, 153:175-181.
31. Watanabe Y., Nakano T., Yutani K., Nishimura H., Kusuoka H., Nakamura H., Nishimura T. Detection of viable cortical neurons using benzodiazepine receptor imaging after reversible focal ischaemia in rats: comparison with regional cerebral blood flow. Eur J Nucl Med 2000, 27:308-313.
32. Yamauchi H., Kudoh T., Kishibe Y., Iwasaki J., Kagawa S. Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study. J Nucl Med 2005, 46:1973-1979.